These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38357407)

  • 1. Comparison of Blood Concentration and Weight-Based Heparin and Protamine Dosing Strategies for Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis.
    Raner G; Hu Y; Trowbridge C; Zhang L; Logan J; Wu X; Zhang X
    Cureus; 2024 Feb; 16(2):e54144. PubMed ID: 38357407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
    Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
    PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood loss after cardiopulmonary bypass, standard vs titrated protamine: a meta-analysis.
    Wang J; Ma HP; Zheng H
    Neth J Med; 2013 Apr; 71(3):123-7. PubMed ID: 23712807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
    Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
    Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
    Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
    J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
    Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
    Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of different heparin dosing regimens for cardiopulmonary bypass on anticoagulation: the HepDOSE pilot study.
    Lwin TN; Mudannayake R; MacDonald S; Arrowsmith JE; Burt C; Besser M; Falter F
    Can J Anaesth; 2024 Feb; 71(2):234-243. PubMed ID: 37985627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized heparin monitoring and management reduces protamine requirements in cardiac surgery on minimal invasive extracorporeal circulation; A prospective randomized study.
    Gkiouliava A; Argiriadou H; Antonitsis P; Goulas A; Papapostolou E; Sarridou D; Karapanagiotidis GT; Anastasiadis K
    Perfusion; 2023 Sep; ():2676591231204284. PubMed ID: 37776194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management.
    Hoenicka M; Rupp P; Müller-Eising K; Deininger S; Kunert A; Liebold A; Gorki H
    J Thromb Haemost; 2015 Jul; 13(7):1196-206. PubMed ID: 25954849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study.
    Runge M; Møller CH; Steinbrüchel DA
    J Extra Corpor Technol; 2009 Mar; 41(1):10-4. PubMed ID: 19361026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Minimum Protamine Dose to Neutralize Heparin at the Completion of Cardiopulmonary Bypass be Significantly Lower than the Conventional Practice?
    Lee MH; Riley W; Shann KG
    J Extra Corpor Technol; 2021 Sep; 53(3):170-176. PubMed ID: 34658407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass.
    Miles LF; Marchiori P; Falter F
    Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pharmacokinetic Model for Protamine Dosing After Cardiopulmonary Bypass.
    Meesters MI; Veerhoek D; de Jong JR; Boer C
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1190-5. PubMed ID: 27493093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine dosing and its impact in cardiac surgery transfusion practice-A retrospective bi-institutional analysis.
    Mondal S; Abuelkasem E; Vesselinov R; Henderson R; Choi S; Mousa A; Zaza KJ; Tanaka KA
    Transfusion; 2024 Mar; 64(3):467-474. PubMed ID: 38264767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.